{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/8580"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/8580","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Inhibition of platelet and vascular smooth muscle function by cyclic nucleotides: Synergism between activators of adenylyl and guanylyl cyclases","abstract":"<p>In platelets, the activators of guanylyl cyclase used were sodium nitroprusside (SNP) and SIN-1 (the active metabolite of molsidomine). PGE$\\sb1,$ a functional analogue of prostacyclin (PGI$\\sb2),$ and adenosine were the activators of platelet adenylyl cyclase studied. Changes in cyclic ($\\sp3$H) nucleotides were measured in platelets prelabelled with ($\\sp3$H) guanine and ($\\sp3$H) adenine. Incubation of labelled platelets with SNP or SIN-1 caused inhibitions of platelet function which were associated with large dose-dependent increases in ($\\sp3$H) cGMP and 1.4 to 3.0-fold increases in ($\\sp3$H) cAMP. However, addition of either SNP or SIN-1 with PGE$\\sb1$ or adenosine, at concentrations of the latter that had little effect alone, caused much larger increases in ($\\sp3$H) cAMP and greatly enhanced the inhibition of platelet function. Experiments with an adenylyl cyclase inhibitor, 2$\\sp\\prime,$5$\\sp\\prime$-dideoxyadenosine (DDA), suggested that these synergistic interactions depend on an enhanced accumulation of cAMP. Hemoglobin inhibited all nitrovasodilator-mediated effects. Cilostamide, a selective inhibitor of platelet cGMP-inhibited cAMP phosphodiesterase (cGI-PDE), had effects identical to those of SNP, suggesting that the actions of the latter depend on inhibition of the same enzyme. Also, the results obtained with M&B 22,948, a cGMP-selective PDE inhibitor, strongly suggest that the increases in platelet ($\\sp3$H) cAMP caused by nitrovasodilators, in the presence or absence of activators of adenylyl cyclase, are mediated by the inhibition of cAMP breakdown of cGMP. To determine if a similar synergism is seen in vascular smooth muscle (VSM), the interactions between isoproterenol and either nitrovasodilators or cAMP-PDE inhibitors were studied. A fast and sensitive prelabelling method was established for the measurement of cyclic nucleotides in cultured vascular smooth muscle cells (VSMC) from rat aorta. Using this method, agonist-induced changes in the cyclic nucleotide levels of two different aortic VSMC lines were studied. (Abstract shortened by UMI.)</p>","abstract_html":"&lt;p&gt;In platelets, the activators of guanylyl cyclase used were sodium nitroprusside (SNP) and SIN-1 (the active metabolite of molsidomine). PGE$\\sb1,$ a functional analogue of prostacyclin (PGI$\\sb2),$ and adenosine were the activators of platelet adenylyl cyclase studied. Changes in cyclic ($\\sp3$H) nucleotides were measured in platelets prelabelled with ($\\sp3$H) guanine and ($\\sp3$H) adenine. Incubation of labelled platelets with SNP or SIN-1 caused inhibitions of platelet function which were associated with large dose-dependent increases in ($\\sp3$H) cGMP and 1.4 to 3.0-fold increases in ($\\sp3$H) cAMP. However, addition of either SNP or SIN-1 with PGE$\\sb1$ or adenosine, at concentrations of the latter that had little effect alone, caused much larger increases in ($\\sp3$H) cAMP and greatly enhanced the inhibition of platelet function. Experiments with an adenylyl cyclase inhibitor, 2$\\sp\\prime,$5$\\sp\\prime$-dideoxyadenosine (DDA), suggested that these synergistic interactions depend on an enhanced accumulation of cAMP. Hemoglobin inhibited all nitrovasodilator-mediated effects. Cilostamide, a selective inhibitor of platelet cGMP-inhibited cAMP phosphodiesterase (cGI-PDE), had effects identical to those of SNP, suggesting that the actions of the latter depend on inhibition of the same enzyme. Also, the results obtained with M&amp;B 22,948, a cGMP-selective PDE inhibitor, strongly suggest that the increases in platelet ($\\sp3$H) cAMP caused by nitrovasodilators, in the presence or absence of activators of adenylyl cyclase, are mediated by the inhibition of cAMP breakdown of cGMP. To determine if a similar synergism is seen in vascular smooth muscle (VSM), the interactions between isoproterenol and either nitrovasodilators or cAMP-PDE inhibitors were studied. A fast and sensitive prelabelling method was established for the measurement of cyclic nucleotides in cultured vascular smooth muscle cells (VSMC) from rat aorta. Using this method, agonist-induced changes in the cyclic nucleotide levels of two different aortic VSMC lines were studied. (Abstract shortened by UMI.)&lt;/p&gt;","abstract_has_math":true,"creators":["Maurice, Hector Donald"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Medical Sciences","school":null,"contributors":[],"advisors":["Haslam, Richard J."],"committee_chairs":[],"committee_members":[],"year":1991,"date_issued":"1991-02","date_published":"1991-02","updated_at":"2026-11-18T19:39:27Z","subjects":["Medical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/23539"],"render_values":[{"text":"https://doi.org/10.71548/23539","href":"https://doi.org/10.71548/23539","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/3774","4791","1716377"],"render_values":[{"text":"opendissertations/3774","href":null,"code":true},{"text":"4791","href":null,"code":true},{"text":"1716377","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/8580","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/8580","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F8580","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Haslam, Richard J."]},{"key":"dc:contributor.department","label":"Department","values":["Medical Sciences"]},{"key":"dc:creator","label":"Author","values":["Maurice, Hector Donald"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-06-18T16:43:18Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-06-18T16:43:18Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2011-01-03"]},{"key":"dc:date.issued","label":"Date","values":["1991-02"]},{"key":"dc:type","label":"Dc Type","values":["thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/3774","4791","1716377"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/8580","https://doi.org/10.71548/23539"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>In platelets, the activators of guanylyl cyclase used were sodium nitroprusside (SNP) and SIN-1 (the active metabolite of molsidomine). PGE$\\sb1,$ a functional analogue of prostacyclin (PGI$\\sb2),$ and adenosine were the activators of platelet adenylyl cyclase studied. Changes in cyclic ($\\sp3$H) nucleotides were measured in platelets prelabelled with ($\\sp3$H) guanine and ($\\sp3$H) adenine. Incubation of labelled platelets with SNP or SIN-1 caused inhibitions of platelet function which were associated with large dose-dependent increases in ($\\sp3$H) cGMP and 1.4 to 3.0-fold increases in ($\\sp3$H) cAMP. However, addition of either SNP or SIN-1 with PGE$\\sb1$ or adenosine, at concentrations of the latter that had little effect alone, caused much larger increases in ($\\sp3$H) cAMP and greatly enhanced the inhibition of platelet function. Experiments with an adenylyl cyclase inhibitor, 2$\\sp\\prime,$5$\\sp\\prime$-dideoxyadenosine (DDA), suggested that these synergistic interactions depend on an enhanced accumulation of cAMP. Hemoglobin inhibited all nitrovasodilator-mediated effects. Cilostamide, a selective inhibitor of platelet cGMP-inhibited cAMP phosphodiesterase (cGI-PDE), had effects identical to those of SNP, suggesting that the actions of the latter depend on inhibition of the same enzyme. Also, the results obtained with M&B 22,948, a cGMP-selective PDE inhibitor, strongly suggest that the increases in platelet ($\\sp3$H) cAMP caused by nitrovasodilators, in the presence or absence of activators of adenylyl cyclase, are mediated by the inhibition of cAMP breakdown of cGMP. To determine if a similar synergism is seen in vascular smooth muscle (VSM), the interactions between isoproterenol and either nitrovasodilators or cAMP-PDE inhibitors were studied. A fast and sensitive prelabelling method was established for the measurement of cyclic nucleotides in cultured vascular smooth muscle cells (VSMC) from rat aorta. Using this method, agonist-induced changes in the cyclic nucleotide levels of two different aortic VSMC lines were studied. (Abstract shortened by UMI.)</p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Doctor of Philosophy (PhD)"]},{"key":"dc:title","label":"Title","values":["Inhibition of platelet and vascular smooth muscle function by cyclic nucleotides: Synergism between activators of adenylyl and guanylyl cyclases"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Haslam, Richard J."],"dc:contributor.department":["Medical Sciences"],"dc:creator":["Maurice, Hector Donald"],"dc:date.accessioned":["2014-06-18T16:43:18Z"],"dc:date.available":["2014-06-18T16:43:18Z"],"dc:date.created":["2011-01-03"],"dc:date.issued":["1991-02"],"dc:description.abstract":["<p>In platelets, the activators of guanylyl cyclase used were sodium nitroprusside (SNP) and SIN-1 (the active metabolite of molsidomine). PGE$\\sb1,$ a functional analogue of prostacyclin (PGI$\\sb2),$ and adenosine were the activators of platelet adenylyl cyclase studied. Changes in cyclic ($\\sp3$H) nucleotides were measured in platelets prelabelled with ($\\sp3$H) guanine and ($\\sp3$H) adenine. Incubation of labelled platelets with SNP or SIN-1 caused inhibitions of platelet function which were associated with large dose-dependent increases in ($\\sp3$H) cGMP and 1.4 to 3.0-fold increases in ($\\sp3$H) cAMP. However, addition of either SNP or SIN-1 with PGE$\\sb1$ or adenosine, at concentrations of the latter that had little effect alone, caused much larger increases in ($\\sp3$H) cAMP and greatly enhanced the inhibition of platelet function. Experiments with an adenylyl cyclase inhibitor, 2$\\sp\\prime,$5$\\sp\\prime$-dideoxyadenosine (DDA), suggested that these synergistic interactions depend on an enhanced accumulation of cAMP. Hemoglobin inhibited all nitrovasodilator-mediated effects. Cilostamide, a selective inhibitor of platelet cGMP-inhibited cAMP phosphodiesterase (cGI-PDE), had effects identical to those of SNP, suggesting that the actions of the latter depend on inhibition of the same enzyme. Also, the results obtained with M&B 22,948, a cGMP-selective PDE inhibitor, strongly suggest that the increases in platelet ($\\sp3$H) cAMP caused by nitrovasodilators, in the presence or absence of activators of adenylyl cyclase, are mediated by the inhibition of cAMP breakdown of cGMP. To determine if a similar synergism is seen in vascular smooth muscle (VSM), the interactions between isoproterenol and either nitrovasodilators or cAMP-PDE inhibitors were studied. A fast and sensitive prelabelling method was established for the measurement of cyclic nucleotides in cultured vascular smooth muscle cells (VSMC) from rat aorta. Using this method, agonist-induced changes in the cyclic nucleotide levels of two different aortic VSMC lines were studied. (Abstract shortened by UMI.)</p>"],"dc:description.degree":["Doctor of Philosophy (PhD)"],"dc:identifier.other":["opendissertations/3774","4791","1716377"],"dc:identifier.uri":["http://hdl.handle.net/11375/8580","https://doi.org/10.71548/23539"],"dc:subject":["Medical Sciences"],"dc:title":["Inhibition of platelet and vascular smooth muscle function by cyclic nucleotides: Synergism between activators of adenylyl and guanylyl cyclases"],"dc:type":["thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:39:27Z"}